National Comprehensive Cancer Network

Interactive CME

NCCN Guidelines® & Clinical Resources

NCCN International Programs – Asia Consensus Statement

View Asia Consensus Statement (ACS) adaptations

In May 2015, representatives of the National Comprehensive Cancer Network® (NCCN®) participated in the Asia Consensus Statement meeting, held during the American Urological Association’s 2015 Annual Meeting (AUA 2015) in New Orleans, Louisiana, United States. This year’s meeting focused on the creation of consensus statements for Bladder and Kidney Cancers.

Representatives of NCCN included Robert W. Carlson, MD, Chief Executive Officer, NCCN; Peter Clark MD, Vanderbilt-Ingram Cancer Center, Chair, NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Panel for Bladder Cancer; Eric Jonasch MD, The University of Texas MD Anderson Cancer Center, Vice-Chair, NCCN Guidelines Panel for Kidney Cancer; and Rashmi Kumar, PhD, Senior Manager of Clinical Content, NCCN.

The 2015 meeting participants included a panel of multidisciplinary specialists from China, Indonesia, Japan, South Korea, and Taiwan, who engaged in consensus discussions that will result in the 2015 Asia Consensus Statements for Bladder and Kidney Cancers. The adaptations will be based on scientific descriptions and analyses of variations in care across numerous regions in Asia.

Moreover, the Asia Consensus Statements for Kidney and Bladder Cancers will be English-language manuscripts designed to provide clinical resources for Asian specialists who are involved in the management of patients with Kidney and Bladder cancers in Asia. NCCN anticipates making these adaptations available on NCCN.org in fall of 2015.

In September 2013, James L. Mohler, MD, Roswell Park Cancer Institute, Chair of the NCCN Prostate Cancer Panel, travelled to Incheon, South Korea to represent NCCN on a panel of multidisciplinary specialists from China, India, Indonesia, Japan, Malaysia, the Philippines, Singapore, South Korea, Taiwan, and Thailand in consensus discussions to successfully update the last version of the Asia Consensus Statement for Prostate Cancer, published in 2011. These discussions included scientific descriptions and analyses of variations in care across numerous regions in Asia.

The Asia Consensus Statement for Prostate Cancer is an English-language manuscript designed to provide a clinical resource for Asian specialists who are involved in the management of patients with prostate cancer in Asia. In addition to NCCN, the Asia Pacific Society of Uro-Oncology, Asian Pacific Prostate Society, and Japan Society of Clinical Oncology collaborated on this update.


View Asia Consensus Statement (ACS) adaptations


Learn more about NCCN global initiatives


If you would like to learn more about translations, how to support translations and regional adaptations of the NCCN Guidelines, or other international programming opportunities, please contact Jorge Bacigalupo, Global Business Development Specialist.